The largest community of pharma leaders

Alnylam Announces New Leadership Appointments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the appointment of Kelley Boucher as the Company’s Senior Vice President (SVP), Chief Human Resources Officer (CHRO) and the promotion of Kevin Fitzgerald, Ph.D., as SVP, Chief Scientific Officer (CSO). “We are thrilled to have Kelley join our executive team and look forward to working with her on building Alnylam for the future, including acquisition of top…



Recent Articles